Researcher

The petition was approved based on the satisfaction of at least three EB-1A criteria: authorship of 16 peer-reviewed journal articles, a high citation count of 1,042 according to Google Scholar, and the completion of 21 peer reviews for scientific journals. Additionally, the work was supported by competitive funding from the National Science Foundation of China (NSFC) and the Science and Technology Program of Guangzhou.

The petition was approved based on a record of 17 peer-reviewed articles and 1,210 citations, demonstrating extensive independent reliance by the research community. The petitioner also provided evidence of 13 completed manuscript reviews for respected journals. Approval was further supported by original contributions in structure-guided HIV vaccine design and nucleic acid-based strategies for SARS-CoV-2.

The petitioner demonstrated extraordinary ability through 33 peer-reviewed journal articles and 883 citations from researchers in 56 countries. She satisfied the EB-1A criteria by performing at least 40 peer reviews and contributing original scientific research in genomics and multiomics. Her work's impact was further validated by funding from a premier Indian government agency and her ranking in the top 5% of authors in microbiology.

The petition was approved based on a strong record of 404 citations and 17 peer-reviewed scientific articles. The petitioner demonstrated active participation in the field by conducting 15 peer reviews for professional journals. Additionally, her work received funding from prestigious organizations including the NIH and the National Space Biomedical Research Institute.